ClinicalTrials.gg
RecruitingNCT07136532Updated Aug 22, 2025

Prediction of Fluid Responsiveness in Paediatric Patients With Septic Shock Using Carotid Doppler Ultrasonography and Echocardiography

An observational study in Septic Shock and Echocardiography Guided Fluid Management, sponsored by Ain Shams University. Recruiting at 1 site in Egypt. Open to participants aged 1 Month to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Ain Shams University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
1 Month to 16 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Shock, Septic by Ain Shams University — 4 open to participants now, 4 under way, none of them phase 3. Shock, Septic · Ain Shams University.

Started
2025
with 1 other
Observational
5 of 10
3 open now
Registered
8th of 10
by date

Among the 10 studies in Shock, Septic by Ain Shams University, this one is one of 2 that started in 2025, is one of 5 observational ones, and was the 8th registered.

Shock, Septic

1,084 studies on the registry are indexed under Shock, Septic; 236 are open to participants now.

Browse Shock, Septic studies →

Open to participants now

4 of the 10 studies in Shock, Septic by Ain Shams University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 137 Shock, Septic studies recruiting now, 103 (75%) set no upper age limit and 18 (13%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.

This study: 1 Month to 16 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Shock, Septic by Ain Shams University, or all of them as a file.
02

Study summary

The goal of this study is to evaluate the role of carotid Doppler and Echocardiography as a predictor of fluid responsiveness in paediatric patients with septic shock.

and To evaluate the diagnostic accuracy of Aortic peak velocity and velocity time integral (VTI)variation in patients with septic shock during their fluid resuscitation phase as a reliable predictor of fluid responsiveness.

Read the detailed description

The goal of this study is to evaluate the role of carotid Doppler and Echocardiography as a predictor of fluid responsiveness in paediatric patients with septic shock.

and To evaluate the diagnostic accuracy of Aortic peak velocity and VTI variation in patients with septic shock during their fluid resuscitation phase as a reliable predictor of fluid responsiveness.All patients included in the study will be evaluated clinically and radiologically at fluid resuscitative phase of septic shock after fluid resuscitation.

This evaluation will include:

  • Clinical examination:

Clinical evaluation will be done initially and after fluid resuscitation:

  • Vital data (systolic, diastolic, and mean blood pressure, heart rate, Temperature).
  • Urine output, capillary perfusion time, Central venous pressure (CVP).
  • Detailed physical examination (chest, heart, and abdomen). • Investigations:

A) Laboratory:

  • Complete blood count.
  • Venous blood gases.
  • C-reactive protein.
  • Kidney function tests.
  • Albumin.
  • Serum lactate.
  • Fibrinogen
  • Serum electrolytes.
  • Fibrinogen to albumin ratio

B) Imaging:

Echocardiography (measurement of stroke volume, stroke volume index, cardiac index, systemic vascular resistance index, Aortic peak velocity and VTI variation,, inferior vena cava (IVC)collapsibility index and IVC distensibility index)

03

Conditions studied

  • Septic Shock
  • Echocardiography Guided Fluid Management

Browse trials for

Keywords

  • pediatric septic shock
  • echocardiography
  • carotid doppler
04

Who can participate

Ages eligible
1 Month to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

o All Patients with septic shock admitted at the PICU during their fluid resuscitative phase during study time will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 1 month to 16 years.
  • Patients with septic shock admitted at the PICU during their fluid resuscitative phase were included.Septic shock was diagnosed according to phoenix sepsis score 2024

Exclusion criteria

  • Exclusion criteria:
  • Acquired and congenital heart disease.
  • Acquired and congenital renal disease.
  • Vascular anomalies (e.g. arteriovenous malformation, aneurysm).
  • Suspected intracranial hypertension.
  • Skin lesions or bandages at the sites of ultrasound or echo-cardiography examinations.
  • Anatomical anomalies of the neck.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • pediatric patients with septic shock

    All patients admitted at Paediatric Intensive care unit (PICU) during the period of the study and met the inclusion criteria. * Sex: Both males and females. * Age: 1 month to 16 years. * Sample size: 50 patients with septic shock admitted at PICU. All patients included in the study will be evaluated clinically and radiologically at fluid resuscitative phase of septic shock after fluid resuscitation. This evaluation will include: • Clinical examination: Clinical evaluation will be done initially and after fluid resuscitation: * Vital data (systolic, diastolic, and mean blood pressure, heart rate, Temperature). * Urine output, capillary perfusion time, Central venous pressure (CVP). * Detailed physical examination • Investigations: A) Laboratory: * Complete blood count. * Venous blood gases. * C-reactive protein. * Kidney function tests. * Albumin. * Serum lactate. -Echocardiography (measurement of stroke volume, stroke volume index,cardiac index) \_carotid doppler ultrasonography

    Diagnostic Test: echocardiography

Interventions

  • Diagnostic testechocardiography

    Echocardiography will be performed using the ultrasound system echocardiographic equipment (Siemens Advanced Clinical Ultrasound Systems Optimized Navigation (ACUSON) P500), carotid doppler ultrasonography (Carotid blood flow and Corrected flow time) by using the ultrasound system echocardiographic equipment (Siemens ACUSON P500) . Those measurements will be done at time zero and upon completion of fluid resuscitation . • Statistical Analysis: All data will be collected, tabulated, and statistically analysed using International Business Machines\_Statistical Package for the Social Sciences (IBM SPSS) version 27.

06

What researchers measure

Primary outcomes

  1. To evaluate the role of carotid Doppler and Echocardiography as a predictor of fluid responsiveness in paediatric patients with septic shock.

    we use carotid Doppler and Echocardiography to predict the fluid responsiveness in paediatric patients with septic shock.

    Time frame: one year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Liteplo AS, Schleifer J, Marill KA, Huang CK, Gouker SK, Ratanski D, Diamond E, Filbin MR, Shokoohi H. Carotid Ultrasound in Assessing Fluid Responsiveness in Patients with Hypotension and Suspected Sepsis. Shock. 2021 Sep 1;56(3):419-424. doi: 10.1097/SHK.0000000000001755. PubMed 33577247 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2025; primary completion for Sep 2026, 12 months later.

Of 189 non-industry observational studies under Shock, Septic, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 202 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2025
First posted
Aug 22, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
Sep 1, 2026
CompletionEst.
Mar 1, 2027
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07136532
Responsible party
Sponsor
First posted
Aug 22, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Aug 22, 2025

Study contacts

Sara sobhy selim, assistant lecturer
Contact
SaraSobhy@med.asu.eg
+2001008668418

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion